{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:40Z","timestamp":1793835880342,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijgc.2026.104794","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:47:52Z","timestamp":1780292872000},"page":"104794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["European Society of Gynaecological Oncology\/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening"],"prefix":"10.1016","volume":"36","author":[{"given":"Elmar","family":"Joura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4708","authenticated-orcid":false,"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-4459","authenticated-orcid":false,"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-6623","authenticated-orcid":false,"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2729-3126","authenticated-orcid":false,"given":"Ico","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9535-5821","authenticated-orcid":false,"given":"Richard","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104794_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ygyno.2021.11.005","article-title":"Global distribution, risk factors, and recent trends for cervical cancer: a worldwide country-level analysis","volume":"164","author":"Huang","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2026.104794_bib2","unstructured":"WHO. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. 2020. (https:\/\/www.who.int\/publications\/i\/item\/9789240014107). accessed date: 23\/02\/2026"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104794_bib3","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104794_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104794_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000531","article-title":"An introduction to the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Schiffman","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ijgc.2026.104794_bib6","article-title":"Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands","volume":"355","author":"Dijkstra","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ijgc.2026.104794_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"Elfstrom","year":"2014","journal-title":"BMJ"},{"issue":"9916","key":"10.1016\/j.ijgc.2026.104794_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104794_bib9","article-title":"Cytology versus HPV testing for cervical cancer screening in the general population","volume":"2018","author":"Koliopoulos","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104794_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijgc.2026.104794_bib11","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2021. 2nd ed. Geneva. (https:\/\/www.who.int\/publications\/i\/item\/9789240030824). accessed date: 23\/02\/2026"},{"key":"10.1016\/j.ijgc.2026.104794_bib12","unstructured":"WHO. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV). 2021. 2nd ed. Geneva. (https:\/\/www.who.int\/publications\/i\/item\/9789240040434) accessed date: 23\/02\/2026"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104794_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","article-title":"Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis","volume":"23","author":"Arbyn","year":"2022","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104794_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/ijgc-2022-004197","article-title":"Quality assurance in human papillomavirus testing for primary cervical screening","volume":"33","author":"Cuschieri","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104794_bib15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ijc.35200","article-title":"Clinically validated HPV assays offer comparable long-term safety in primary cervical cancer screening: a 9-year follow-up of a population-based screening cohort","volume":"156","author":"O\u0161trbenk Valen\u010dak","year":"2025","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104794_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21106\/ijma.12","article-title":"Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development","volume":"1","author":"Singh","year":"2012","journal-title":"Int J MCH AIDS"},{"issue":"19","key":"10.1016\/j.ijgc.2026.104794_bib17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.vaccine.2018.03.024","article-title":"Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination","volume":"36","author":"Ng","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ijgc.2026.104794_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1067299","article-title":"Gender neutral HPV vaccination programs: reconsidering policies to expand cancer prevention globally","volume":"11","author":"Dykens","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijgc.2026.104794_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2022.200240","article-title":"Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer >\/=15 years later","volume":"14","author":"Inturrisi","year":"2022","journal-title":"Tumour Virus Res."},{"issue":"5","key":"10.1016\/j.ijgc.2026.104794_bib20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ijc.35289","article-title":"Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and\/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial","volume":"156","author":"Verhoef","year":"2025","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104794_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.amepre.2018.03.013","article-title":"Cervical cancer incidence in Young U.S. females after human papillomavirus vaccine introduction","volume":"55","author":"Guo","year":"2018","journal-title":"Am J Prev Med"},{"issue":"12","key":"10.1016\/j.ijgc.2026.104794_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050669","article-title":"Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial","volume":"11","author":"Lehtinen","year":"2021","journal-title":"BMJ Open"},{"issue":"14","key":"10.1016\/j.ijgc.2026.104794_bib23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.ijgc.2026.104794_bib24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/ijc.35228","article-title":"Elimination of cervical cancer by refined vaccination and screening","volume":"156","author":"Lehtinen","year":"2025","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104794_bib25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/ijc.35044","article-title":"Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions","volume":"155","author":"Louvanto","year":"2024","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2026.104794_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1470-2045(22)00334-5","article-title":"Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis","volume":"23","author":"Athanasiou","year":"2022","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104794_bib27","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijgc.2026.104794_bib28","article-title":"HPV testing of self-samples: influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer","volume":"14","author":"Arbyn","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ijgc.2026.104794_bib29","series-title":"Validated HPV Tests Usable in Cervical Cancer Screening on Clinician-Collected Cervical Specimens","author":"Arbyn","year":"2024"},{"key":"10.1016\/j.ijgc.2026.104794_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","article-title":"VALHUDES: a protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples","volume":"107","author":"Arbyn","year":"2018","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104794_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41597-024-03519-2","article-title":"The Swedish cervical screening cohort","volume":"11","author":"Dillner","year":"2024","journal-title":"Sci Data"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104794_bib32","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/pon.5897","article-title":"Psychosocial impact of testing human papillomavirus positive in Australia\u2019s human papillomavirus-based cervical screening program: a cross-sectional survey","volume":"31","author":"Chadwick","year":"2022","journal-title":"Psycho-oncology"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104794_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/17437199.2020.1762106","article-title":"Emotional response to testing positive for human papillomavirus at cervical cancer screening: a mixed method systematic review with meta-analysis","volume":"15","author":"McBride","year":"2021","journal-title":"Health Psychol Rev"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26003257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:48:13Z","timestamp":1785790093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26003257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1048891X26003257"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104794","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Society of Gynaecological Oncology\/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104794"}}